Charles A. Reinhart, III

2021

In 2021, Charles A. Reinhart, III earned a total compensation of $1.7M as Chief Financial Officer at Pacira Pharmaceuticals, a 17% decrease compared to previous year.

Compensation breakdown

Bonus$230,200
Non-Equity Incentive Plan$165,030
Option Awards$416,178
Salary$460,400
Stock Awards$365,760
Other$25,168
Total$1,662,736

Reinhart received $460.4K in salary, accounting for 28% of the total pay in 2021.

Reinhart also received $230.2K in bonus, $165K in non-equity incentive plan, $416.2K in option awards, $365.8K in stock awards and $25.2K in other compensation.

Rankings

In 2021, Charles A. Reinhart, III's compensation ranked 6,803rd out of 12,406 executives tracked by ExecPay. In other words, Reinhart earned more than 45.2% of executives.

ClassificationRankingPercentile
All
6,803
out of 12,406
45th
Division
Manufacturing
2,954
out of 5,494
46th
Major group
Chemicals And Allied Products
1,306
out of 2,369
45th
Industry group
Drugs
1,164
out of 2,090
44th
Industry
Pharmaceutical Preparations
848
out of 1,537
45th

Pay ratio

Charles A. Reinhart, III's Pay$1,662,736
Median Employee's Pay$199,797
Pay Ratio

8

to 1

In 2021, the annual total compensation of Charles A. Reinhart, III was $1,662,736.

The annual total compensation of the median employee at Pacira Pharmaceuticals was $199,797.

The ratio of Charles A. Reinhart, III's pay to the pay of median employee was therefore 8 to one.

Source: SEC filing on April 22, 2022.

Reinhart's colleagues

We found four more compensation records of executives who worked with Charles A. Reinhart, III at Pacira Pharmaceuticals in 2021.

2021

David Stack

Pacira Pharmaceuticals

Chief Executive Officer

2021

Roy Winston

Pacira Pharmaceuticals

Chief Medical Officer

2021

Jonathan Slonin

Pacira Pharmaceuticals

Chief Clinical Officer

2021

Max Reinhardt

Pacira Pharmaceuticals

President, Rest of World

News

You may also like